Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and Gi Protein-independent ERK1/2 Kinase Activation
Kwang H. Ahn, Mariam M. Mahmoud, Debra A. Kendall
Journal of Biological Chemistry (2012) Vol. 287, Iss. 15, pp. 12070-12082
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 20, pp. 4790-4805
Open Access | Times Cited: 862
G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 419
Pregnenolone Can Protect the Brain from Cannabis Intoxication
Monique Vallée, S. Vitiello, Luigi Bellocchio, et al.
Science (2014) Vol. 343, Iss. 6166, pp. 94-98
Open Access | Times Cited: 275
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili, et al.
British Journal of Pharmacology (2018) Vol. 176, Iss. 10, pp. 1455-1469
Open Access | Times Cited: 270
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, et al.
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 9, pp. 692-708
Open Access | Times Cited: 239
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster, P. Jeffrey Conn
Neuron (2017) Vol. 94, Iss. 3, pp. 431-446
Open Access | Times Cited: 218
Advances in G Protein-Coupled Receptor Allostery: From Function to Structure
Arthur Christopoulos
Molecular Pharmacology (2014) Vol. 86, Iss. 5, pp. 463-478
Open Access | Times Cited: 213
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Cannabinoid CB1and CB2Receptor Signaling and Bias
Mikkel Søes Ibsen, Mark Connor, Michelle Glass
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 48-60
Open Access | Times Cited: 195
Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
Lauren M. Slosky, Marc G. Caron, Lawrence S Barak
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 283-299
Open Access | Times Cited: 136
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 100
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 22
Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor
Fabrício A. Pamplona, Juliano Ferreira, Octávio Menezes de Lima, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 51, pp. 21134-21139
Open Access | Times Cited: 166
Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors
Craig W. Lindsley, Kyle A. Emmitte, Corey R. Hopkins, et al.
Chemical Reviews (2016) Vol. 116, Iss. 11, pp. 6707-6741
Open Access | Times Cited: 166
Distinct Roles of β-Arrestin 1 and β-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1)
Kwang H. Ahn, Mariam M. Mahmoud, Joong‐Youn Shim, et al.
Journal of Biological Chemistry (2013) Vol. 288, Iss. 14, pp. 9790-9800
Open Access | Times Cited: 128
Biased Agonism and Biased Allosteric Modulation at the CB1Cannabinoid Receptor
Elham Khajehali, Daniel T. Malone, Michelle Glass, et al.
Molecular Pharmacology (2015) Vol. 88, Iss. 2, pp. 368-379
Open Access | Times Cited: 128
The Endocannabinoid Signaling System in the CNS
Cecilia J. Hillard
International review of neurobiology (2015), pp. 1-47
Open Access | Times Cited: 111
CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
Gemma L. Baillie, James G. Horswill, Sharon Anavi‐Goffer, et al.
Molecular Pharmacology (2012) Vol. 83, Iss. 2, pp. 322-338
Open Access | Times Cited: 110
Real‐time characterization of cannabinoid receptor 1 (CB1) allosteric modulators reveals novel mechanism of action
Erin E. Cawston, William Redmond, Courtney M Breen, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 4, pp. 893-907
Open Access | Times Cited: 108
New Insights in Cannabinoid Receptor Structure and Signaling
Lingyan Ye, Zheng Cao, Weiwei Wang, et al.
Current Molecular Pharmacology (2019) Vol. 12, Iss. 3, pp. 239-248
Open Access | Times Cited: 105
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen, Jun‐Xu Li, Brian F. Thomas, et al.
Medicinal Research Reviews (2016) Vol. 37, Iss. 3, pp. 441-474
Open Access | Times Cited: 89
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors
David B. Finlay, Kathleen J. Sircombe, Mhairi Nimick, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 83
CB1 Cannabinoid Receptor Signaling and Biased Signaling
Luciana M. Leo, Mary E. Abood
Molecules (2021) Vol. 26, Iss. 17, pp. 5413-5413
Open Access | Times Cited: 74
A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1
Xiaoyan Wang, Dongsheng Liu, Ling Shen, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 40, pp. 16320-16325
Closed Access | Times Cited: 65
Page 1 - Next Page

Scroll to top